Conditioning with Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

In this prospective study 60 patients of median age 46 (range 5–60) years, with acute myeloid leukemia (AML; n=44), acute lymphoblastic leukemia (ALL; n=3), or myelodysplastic syndrome (MDS; n=13) were conditioned for allogeneic hematopoietic cell transplantation with a treosulfan/fludarabine combin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nemecek, Eneida R., Guthrie, Katherine A., Sorror, Mohamed L., Wood, Brent L., Doney, Kristine C., Hilger, Ralf A., Scott, Bart L., Kovacsovics, Tibor J., Maziarz, Richard T., Woolfrey, Ann E., Bedalov, Antonio, Sanders, Jean E., Pagel, John M., Sickle, Eileen J., Witherspoon, Robert, Flowers, Mary E., Appelbaum, Frederick R., Deeg, H. Joachim
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974965/
https://ncbi.nlm.nih.gov/pubmed/20685259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.05.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares